Hiroko Shigemi Selected Research

Hiroko Shigemi Research Topics

Disease

4	Sepsis (Septicemia) 02/2021 - 05/2012
3	Neoplasms (Cancer) 03/2021 - 04/2019
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020 - 07/2013
3	Leukemia 04/2014 - 07/2013
2	Infections 02/2021 - 08/2019
2	Myeloid Leukemia (Leukemia, Myelocytic) 10/2014 - 04/2014
1	Febrile Neutropenia 10/2022
1	Invasive Fungal Infections 10/2022
1	Liver Diseases (Liver Disease) 10/2022
1	Mycoses (Diseases, Fungus) 10/2022
1	Neutropenia 10/2022
1	Hematologic Neoplasms (Hematological Malignancy) 10/2022
1	Critical Illness (Critically Ill) 02/2022
1	Fever (Fevers) 03/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2021
1	Trichosporonosis 03/2021
1	Fungemia 03/2021
1	Bacteremia 02/2021
1	Inflammation (Inflammations) 01/2020
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2020
1	Cytokine Release Syndrome 01/2020
1	Lung Neoplasms (Lung Cancer) 07/2019
1	Respiratory Insufficiency (Respiratory Failure) 04/2019
1	Vasculitis (Vasculitides) 04/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2019
1	Multiple Myeloma 12/2017
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2014
1	Acute Promyelocytic Leukemia 01/2014
1	Polyploidy 07/2013
1	Pemphigus (Pemphigus Vulgaris) 05/2012
1	Mental Disorders (Mental Disorder) 10/2007
1	Autistic Disorder (Autism) 10/2007

Drug/Important Bio-Agent (IBA)

3	Cytarabine (Cytosar-U)FDA LinkGeneric 10/2020 - 07/2013
2	liposomal amphotericin B FDA Link 03/2021 - 04/2019
2	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 02/2021
2	Clofarabine (Clolar)FDA Link 10/2020 - 04/2014
2	Prednisolone (Predate)FDA LinkGeneric 04/2019 - 05/2012
1	ElectrolytesIBA 10/2022
1	Antifungal AgentsIBA 03/2021
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2021
1	Micafungin (FK463)FDA Link 03/2021
1	EchinocandinsIBA 03/2021
1	Fluconazole (Zonal)FDA LinkGeneric 03/2021
1	Pharmaceutical PreparationsIBA 10/2020
1	venetoclaxIBA 10/2020
1	alvocidib (flavopiridol)IBA 10/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	ChemokinesIBA 01/2020
1	CytokinesIBA 01/2020
1	Minocycline (Cyclops)FDA LinkGeneric 01/2020
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2020
1	TOR Serine-Threonine KinasesIBA 01/2020
1	Deoxyglucose (2 Deoxy D glucose)IBA 01/2020
1	NivolumabIBA 01/2020
1	alovudineIBA 07/2019
1	PlatinumIBA 07/2019
1	Ribosomal RNAIBA 04/2019
1	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 04/2019
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Protons (Proton)IBA 01/2019
1	Connective Tissue Growth FactorIBA 01/2019
1	sepantroniumIBA 12/2017
1	Bortezomib (Velcade)FDA Link 12/2017
1	SurvivinIBA 12/2017
1	Gemtuzumab (Mylotarg)FDA Link 10/2014
1	olaparibIBA 10/2014
1	9-arabinofuranosylguanineIBA 07/2014
1	Buthionine SulfoximineIBA 01/2014
1	Arsenic Trioxide (Trisenox)FDA Link 01/2014
1	AZD 1152-HQPAIBA 07/2013
1	2- ((3- ((4- ((5- (2- ((3- fluorophenyl)amino)- 2- oxoethyl)- 1H- pyrazol- 3- yl)amino)quinazolin- 7- yl)oxy)propyl)(ethyl)amino)ethyl dihydrogen phosphateIBA 07/2013
1	Proteins (Proteins, Gene)FDA Link 10/2007
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2007

Therapy/Procedure

5	Therapeutics 10/2022 - 01/2014
4	Drug Therapy (Chemotherapy) 10/2022 - 07/2013
1	Hematopoietic Stem Cell Transplantation 10/2022
1	Mechanical Ventilators (Ventilator) 02/2022
1	Lasers (Laser) 02/2021
1	Catheters 11/2019
1	Hand Hygiene 08/2019